Journal of Integrative Neuroscience-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2200128, encodeId=2d4222001287f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一个多月了，还在peer review，请问这个杂志的审稿速度咋样，很慌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5be79155125, createdName=ms9000001054284223, createdTime=Wed Apr 24 14:08:55 CST 2024, time=2024-04-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198714, encodeId=a75a2198e14bd, content=请问一下这个杂志接收临床研究的文章吗？是否需要提供患者的原始数据？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65861397214, createdName=chenyongdaniel, createdTime=Tue Apr 16 01:29:50 CST 2024, time=2024-04-16, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2180882, encodeId=f19b2180882da, content=..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed6c8739732, createdName=ms1000002125960899, createdTime=Fri Jan 12 01:07:59 CST 2024, time=2024-01-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=591339, encodeId=6cce5913394f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投了一篇综述，送审很快，1个月后收到三个审稿人意见，比较中肯，对修稿帮助很大，认真修改了文章，再次送审，3周后返回直接录用。效率很高，期间和编辑通过几次邮件，基本都是秒回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd6e2356258, createdName=122c0493m86(暂无昵称), createdTime=Wed May 20 20:26:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574838, encodeId=704f5e483848, content=投稿1天变成decision in process，2天后变成revise，现在一直是，请问各位，这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aee52167475, createdName=1204566cm41(暂无昵称), createdTime=Thu Aug 15 00:00:00 CST 2019, time=2019-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113030, encodeId=feec21130303d, content=请问做分子机制需要提交所有的原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2e06431458, createdName=ms3000002026677147, createdTime=Sat Feb 04 18:33:13 CST 2023, time=2023-02-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111102, encodeId=1d45211110209, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：神经介入方向； 我是邀稿的，速度很快，1个月不到，要求比较低； 适合发点小东西，版面费2k刀（注意这个）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/16/e92e0d4a11f64c95514f68e46da6590a.jpg, createdBy=51fb2303021, createdName=errormore, createdTime=Sat Jan 21 19:38:41 CST 2023, time=2023-01-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=578255, encodeId=9c375e82550a, content=现在是oa收费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aee52167475, createdName=1204566cm41(暂无昵称), createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231110, encodeId=2b4b1231110ce, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：peer review 快一个月了，一直没有消息，什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2f25326618, createdName=148bdbbbm57暂无昵称, createdTime=Thu Jul 07 10:21:16 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854981, encodeId=587585498166, content=昨天刚投了一篇结题文章，MedSci上面的关于这本期刊的网址信息不对，我自己通过web of science找到了准确的官方信息： 期刊官方网站：https://jin.imrpress.com/ 期刊投稿网址：https://www.editorialmanager.com/joins/default.aspx , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Fri Nov 15 11:13:58 CST 2019, time=2019-11-15, status=1, ipAttribution=)]

2024-04-24 ms9000001054284223 来自浙江省

审稿速度:3.0 | 投稿命中率:50.0
经验分享：投了一个多月了，还在peer review，请问这个杂志的审稿速度咋样，很慌。

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2200128, encodeId=2d4222001287f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一个多月了，还在peer review，请问这个杂志的审稿速度咋样，很慌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5be79155125, createdName=ms9000001054284223, createdTime=Wed Apr 24 14:08:55 CST 2024, time=2024-04-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198714, encodeId=a75a2198e14bd, content=请问一下这个杂志接收临床研究的文章吗？是否需要提供患者的原始数据？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65861397214, createdName=chenyongdaniel, createdTime=Tue Apr 16 01:29:50 CST 2024, time=2024-04-16, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2180882, encodeId=f19b2180882da, content=..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed6c8739732, createdName=ms1000002125960899, createdTime=Fri Jan 12 01:07:59 CST 2024, time=2024-01-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=591339, encodeId=6cce5913394f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投了一篇综述，送审很快，1个月后收到三个审稿人意见，比较中肯，对修稿帮助很大，认真修改了文章，再次送审，3周后返回直接录用。效率很高，期间和编辑通过几次邮件，基本都是秒回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd6e2356258, createdName=122c0493m86(暂无昵称), createdTime=Wed May 20 20:26:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574838, encodeId=704f5e483848, content=投稿1天变成decision in process，2天后变成revise，现在一直是，请问各位，这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aee52167475, createdName=1204566cm41(暂无昵称), createdTime=Thu Aug 15 00:00:00 CST 2019, time=2019-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113030, encodeId=feec21130303d, content=请问做分子机制需要提交所有的原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2e06431458, createdName=ms3000002026677147, createdTime=Sat Feb 04 18:33:13 CST 2023, time=2023-02-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111102, encodeId=1d45211110209, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：神经介入方向； 我是邀稿的，速度很快，1个月不到，要求比较低； 适合发点小东西，版面费2k刀（注意这个）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/16/e92e0d4a11f64c95514f68e46da6590a.jpg, createdBy=51fb2303021, createdName=errormore, createdTime=Sat Jan 21 19:38:41 CST 2023, time=2023-01-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=578255, encodeId=9c375e82550a, content=现在是oa收费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aee52167475, createdName=1204566cm41(暂无昵称), createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231110, encodeId=2b4b1231110ce, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：peer review 快一个月了，一直没有消息，什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2f25326618, createdName=148bdbbbm57暂无昵称, createdTime=Thu Jul 07 10:21:16 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854981, encodeId=587585498166, content=昨天刚投了一篇结题文章，MedSci上面的关于这本期刊的网址信息不对，我自己通过web of science找到了准确的官方信息： 期刊官方网站：https://jin.imrpress.com/ 期刊投稿网址：https://www.editorialmanager.com/joins/default.aspx , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Fri Nov 15 11:13:58 CST 2019, time=2019-11-15, status=1, ipAttribution=)]

2024-04-16 chenyongdaniel 来自加利福尼亚

请问一下这个杂志接收临床研究的文章吗？是否需要提供患者的原始数据？

4 0

[GetPortalCommentsPageByObjectIdResponse(id=2200128, encodeId=2d4222001287f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一个多月了，还在peer review，请问这个杂志的审稿速度咋样，很慌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5be79155125, createdName=ms9000001054284223, createdTime=Wed Apr 24 14:08:55 CST 2024, time=2024-04-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198714, encodeId=a75a2198e14bd, content=请问一下这个杂志接收临床研究的文章吗？是否需要提供患者的原始数据？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65861397214, createdName=chenyongdaniel, createdTime=Tue Apr 16 01:29:50 CST 2024, time=2024-04-16, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2180882, encodeId=f19b2180882da, content=..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed6c8739732, createdName=ms1000002125960899, createdTime=Fri Jan 12 01:07:59 CST 2024, time=2024-01-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=591339, encodeId=6cce5913394f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投了一篇综述，送审很快，1个月后收到三个审稿人意见，比较中肯，对修稿帮助很大，认真修改了文章，再次送审，3周后返回直接录用。效率很高，期间和编辑通过几次邮件，基本都是秒回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd6e2356258, createdName=122c0493m86(暂无昵称), createdTime=Wed May 20 20:26:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574838, encodeId=704f5e483848, content=投稿1天变成decision in process，2天后变成revise，现在一直是，请问各位，这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aee52167475, createdName=1204566cm41(暂无昵称), createdTime=Thu Aug 15 00:00:00 CST 2019, time=2019-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113030, encodeId=feec21130303d, content=请问做分子机制需要提交所有的原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2e06431458, createdName=ms3000002026677147, createdTime=Sat Feb 04 18:33:13 CST 2023, time=2023-02-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111102, encodeId=1d45211110209, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：神经介入方向； 我是邀稿的，速度很快，1个月不到，要求比较低； 适合发点小东西，版面费2k刀（注意这个）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/16/e92e0d4a11f64c95514f68e46da6590a.jpg, createdBy=51fb2303021, createdName=errormore, createdTime=Sat Jan 21 19:38:41 CST 2023, time=2023-01-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=578255, encodeId=9c375e82550a, content=现在是oa收费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aee52167475, createdName=1204566cm41(暂无昵称), createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231110, encodeId=2b4b1231110ce, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：peer review 快一个月了，一直没有消息，什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2f25326618, createdName=148bdbbbm57暂无昵称, createdTime=Thu Jul 07 10:21:16 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854981, encodeId=587585498166, content=昨天刚投了一篇结题文章，MedSci上面的关于这本期刊的网址信息不对，我自己通过web of science找到了准确的官方信息： 期刊官方网站：https://jin.imrpress.com/ 期刊投稿网址：https://www.editorialmanager.com/joins/default.aspx , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Fri Nov 15 11:13:58 CST 2019, time=2019-11-15, status=1, ipAttribution=)]

2024-01-12 ms1000002125960899 来自浙江省

...

15 0

[GetPortalCommentsPageByObjectIdResponse(id=2200128, encodeId=2d4222001287f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一个多月了，还在peer review，请问这个杂志的审稿速度咋样，很慌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5be79155125, createdName=ms9000001054284223, createdTime=Wed Apr 24 14:08:55 CST 2024, time=2024-04-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198714, encodeId=a75a2198e14bd, content=请问一下这个杂志接收临床研究的文章吗？是否需要提供患者的原始数据？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65861397214, createdName=chenyongdaniel, createdTime=Tue Apr 16 01:29:50 CST 2024, time=2024-04-16, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2180882, encodeId=f19b2180882da, content=..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed6c8739732, createdName=ms1000002125960899, createdTime=Fri Jan 12 01:07:59 CST 2024, time=2024-01-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=591339, encodeId=6cce5913394f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投了一篇综述，送审很快，1个月后收到三个审稿人意见，比较中肯，对修稿帮助很大，认真修改了文章，再次送审，3周后返回直接录用。效率很高，期间和编辑通过几次邮件，基本都是秒回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd6e2356258, createdName=122c0493m86(暂无昵称), createdTime=Wed May 20 20:26:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574838, encodeId=704f5e483848, content=投稿1天变成decision in process，2天后变成revise，现在一直是，请问各位，这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aee52167475, createdName=1204566cm41(暂无昵称), createdTime=Thu Aug 15 00:00:00 CST 2019, time=2019-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113030, encodeId=feec21130303d, content=请问做分子机制需要提交所有的原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2e06431458, createdName=ms3000002026677147, createdTime=Sat Feb 04 18:33:13 CST 2023, time=2023-02-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111102, encodeId=1d45211110209, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：神经介入方向； 我是邀稿的，速度很快，1个月不到，要求比较低； 适合发点小东西，版面费2k刀（注意这个）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/16/e92e0d4a11f64c95514f68e46da6590a.jpg, createdBy=51fb2303021, createdName=errormore, createdTime=Sat Jan 21 19:38:41 CST 2023, time=2023-01-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=578255, encodeId=9c375e82550a, content=现在是oa收费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aee52167475, createdName=1204566cm41(暂无昵称), createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231110, encodeId=2b4b1231110ce, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：peer review 快一个月了，一直没有消息，什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2f25326618, createdName=148bdbbbm57暂无昵称, createdTime=Thu Jul 07 10:21:16 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854981, encodeId=587585498166, content=昨天刚投了一篇结题文章，MedSci上面的关于这本期刊的网址信息不对，我自己通过web of science找到了准确的官方信息： 期刊官方网站：https://jin.imrpress.com/ 期刊投稿网址：https://www.editorialmanager.com/joins/default.aspx , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Fri Nov 15 11:13:58 CST 2019, time=2019-11-15, status=1, ipAttribution=)]

2020-05-20 122c0493m86(暂无昵称)

审稿速度:1.0 | 投稿命中率:75.0
经验分享：投了一篇综述，送审很快，1个月后收到三个审稿人意见，比较中肯，对修稿帮助很大，认真修改了文章，再次送审，3周后返回直接录用。效率很高，期间和编辑通过几次邮件，基本都是秒回。

126 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200128, encodeId=2d4222001287f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一个多月了，还在peer review，请问这个杂志的审稿速度咋样，很慌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5be79155125, createdName=ms9000001054284223, createdTime=Wed Apr 24 14:08:55 CST 2024, time=2024-04-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198714, encodeId=a75a2198e14bd, content=请问一下这个杂志接收临床研究的文章吗？是否需要提供患者的原始数据？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65861397214, createdName=chenyongdaniel, createdTime=Tue Apr 16 01:29:50 CST 2024, time=2024-04-16, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2180882, encodeId=f19b2180882da, content=..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed6c8739732, createdName=ms1000002125960899, createdTime=Fri Jan 12 01:07:59 CST 2024, time=2024-01-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=591339, encodeId=6cce5913394f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投了一篇综述，送审很快，1个月后收到三个审稿人意见，比较中肯，对修稿帮助很大，认真修改了文章，再次送审，3周后返回直接录用。效率很高，期间和编辑通过几次邮件，基本都是秒回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd6e2356258, createdName=122c0493m86(暂无昵称), createdTime=Wed May 20 20:26:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574838, encodeId=704f5e483848, content=投稿1天变成decision in process，2天后变成revise，现在一直是，请问各位，这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aee52167475, createdName=1204566cm41(暂无昵称), createdTime=Thu Aug 15 00:00:00 CST 2019, time=2019-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113030, encodeId=feec21130303d, content=请问做分子机制需要提交所有的原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2e06431458, createdName=ms3000002026677147, createdTime=Sat Feb 04 18:33:13 CST 2023, time=2023-02-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111102, encodeId=1d45211110209, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：神经介入方向； 我是邀稿的，速度很快，1个月不到，要求比较低； 适合发点小东西，版面费2k刀（注意这个）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/16/e92e0d4a11f64c95514f68e46da6590a.jpg, createdBy=51fb2303021, createdName=errormore, createdTime=Sat Jan 21 19:38:41 CST 2023, time=2023-01-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=578255, encodeId=9c375e82550a, content=现在是oa收费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aee52167475, createdName=1204566cm41(暂无昵称), createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231110, encodeId=2b4b1231110ce, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：peer review 快一个月了，一直没有消息，什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2f25326618, createdName=148bdbbbm57暂无昵称, createdTime=Thu Jul 07 10:21:16 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854981, encodeId=587585498166, content=昨天刚投了一篇结题文章，MedSci上面的关于这本期刊的网址信息不对，我自己通过web of science找到了准确的官方信息： 期刊官方网站：https://jin.imrpress.com/ 期刊投稿网址：https://www.editorialmanager.com/joins/default.aspx , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Fri Nov 15 11:13:58 CST 2019, time=2019-11-15, status=1, ipAttribution=)]

2019-08-15 1204566cm41(暂无昵称)

投稿1天变成decision in process，2天后变成revise，现在一直是，请问各位，这是什么情况？

111 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200128, encodeId=2d4222001287f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一个多月了，还在peer review，请问这个杂志的审稿速度咋样，很慌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5be79155125, createdName=ms9000001054284223, createdTime=Wed Apr 24 14:08:55 CST 2024, time=2024-04-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198714, encodeId=a75a2198e14bd, content=请问一下这个杂志接收临床研究的文章吗？是否需要提供患者的原始数据？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65861397214, createdName=chenyongdaniel, createdTime=Tue Apr 16 01:29:50 CST 2024, time=2024-04-16, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2180882, encodeId=f19b2180882da, content=..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed6c8739732, createdName=ms1000002125960899, createdTime=Fri Jan 12 01:07:59 CST 2024, time=2024-01-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=591339, encodeId=6cce5913394f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投了一篇综述，送审很快，1个月后收到三个审稿人意见，比较中肯，对修稿帮助很大，认真修改了文章，再次送审，3周后返回直接录用。效率很高，期间和编辑通过几次邮件，基本都是秒回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd6e2356258, createdName=122c0493m86(暂无昵称), createdTime=Wed May 20 20:26:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574838, encodeId=704f5e483848, content=投稿1天变成decision in process，2天后变成revise，现在一直是，请问各位，这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aee52167475, createdName=1204566cm41(暂无昵称), createdTime=Thu Aug 15 00:00:00 CST 2019, time=2019-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113030, encodeId=feec21130303d, content=请问做分子机制需要提交所有的原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2e06431458, createdName=ms3000002026677147, createdTime=Sat Feb 04 18:33:13 CST 2023, time=2023-02-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111102, encodeId=1d45211110209, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：神经介入方向； 我是邀稿的，速度很快，1个月不到，要求比较低； 适合发点小东西，版面费2k刀（注意这个）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/16/e92e0d4a11f64c95514f68e46da6590a.jpg, createdBy=51fb2303021, createdName=errormore, createdTime=Sat Jan 21 19:38:41 CST 2023, time=2023-01-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=578255, encodeId=9c375e82550a, content=现在是oa收费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aee52167475, createdName=1204566cm41(暂无昵称), createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231110, encodeId=2b4b1231110ce, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：peer review 快一个月了，一直没有消息，什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2f25326618, createdName=148bdbbbm57暂无昵称, createdTime=Thu Jul 07 10:21:16 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854981, encodeId=587585498166, content=昨天刚投了一篇结题文章，MedSci上面的关于这本期刊的网址信息不对，我自己通过web of science找到了准确的官方信息： 期刊官方网站：https://jin.imrpress.com/ 期刊投稿网址：https://www.editorialmanager.com/joins/default.aspx , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Fri Nov 15 11:13:58 CST 2019, time=2019-11-15, status=1, ipAttribution=)]

2023-02-04 ms3000002026677147 来自安徽省

请问做分子机制需要提交所有的原始数据吗？

39 0

[GetPortalCommentsPageByObjectIdResponse(id=2200128, encodeId=2d4222001287f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一个多月了，还在peer review，请问这个杂志的审稿速度咋样，很慌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5be79155125, createdName=ms9000001054284223, createdTime=Wed Apr 24 14:08:55 CST 2024, time=2024-04-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198714, encodeId=a75a2198e14bd, content=请问一下这个杂志接收临床研究的文章吗？是否需要提供患者的原始数据？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65861397214, createdName=chenyongdaniel, createdTime=Tue Apr 16 01:29:50 CST 2024, time=2024-04-16, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2180882, encodeId=f19b2180882da, content=..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed6c8739732, createdName=ms1000002125960899, createdTime=Fri Jan 12 01:07:59 CST 2024, time=2024-01-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=591339, encodeId=6cce5913394f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投了一篇综述，送审很快，1个月后收到三个审稿人意见，比较中肯，对修稿帮助很大，认真修改了文章，再次送审，3周后返回直接录用。效率很高，期间和编辑通过几次邮件，基本都是秒回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd6e2356258, createdName=122c0493m86(暂无昵称), createdTime=Wed May 20 20:26:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574838, encodeId=704f5e483848, content=投稿1天变成decision in process，2天后变成revise，现在一直是，请问各位，这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aee52167475, createdName=1204566cm41(暂无昵称), createdTime=Thu Aug 15 00:00:00 CST 2019, time=2019-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113030, encodeId=feec21130303d, content=请问做分子机制需要提交所有的原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2e06431458, createdName=ms3000002026677147, createdTime=Sat Feb 04 18:33:13 CST 2023, time=2023-02-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111102, encodeId=1d45211110209, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：神经介入方向； 我是邀稿的，速度很快，1个月不到，要求比较低； 适合发点小东西，版面费2k刀（注意这个）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/16/e92e0d4a11f64c95514f68e46da6590a.jpg, createdBy=51fb2303021, createdName=errormore, createdTime=Sat Jan 21 19:38:41 CST 2023, time=2023-01-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=578255, encodeId=9c375e82550a, content=现在是oa收费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aee52167475, createdName=1204566cm41(暂无昵称), createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231110, encodeId=2b4b1231110ce, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：peer review 快一个月了，一直没有消息，什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2f25326618, createdName=148bdbbbm57暂无昵称, createdTime=Thu Jul 07 10:21:16 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854981, encodeId=587585498166, content=昨天刚投了一篇结题文章，MedSci上面的关于这本期刊的网址信息不对，我自己通过web of science找到了准确的官方信息： 期刊官方网站：https://jin.imrpress.com/ 期刊投稿网址：https://www.editorialmanager.com/joins/default.aspx , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Fri Nov 15 11:13:58 CST 2019, time=2019-11-15, status=1, ipAttribution=)]

2023-01-21 errormore 来自江苏省

审稿速度:1.0 | 投稿命中率:95.0
经验分享：神经介入方向；
我是邀稿的，速度很快，1个月不到，要求比较低；
适合发点小东西，版面费2k刀（注意这个）

43 0

[GetPortalCommentsPageByObjectIdResponse(id=2200128, encodeId=2d4222001287f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一个多月了，还在peer review，请问这个杂志的审稿速度咋样，很慌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5be79155125, createdName=ms9000001054284223, createdTime=Wed Apr 24 14:08:55 CST 2024, time=2024-04-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198714, encodeId=a75a2198e14bd, content=请问一下这个杂志接收临床研究的文章吗？是否需要提供患者的原始数据？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65861397214, createdName=chenyongdaniel, createdTime=Tue Apr 16 01:29:50 CST 2024, time=2024-04-16, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2180882, encodeId=f19b2180882da, content=..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed6c8739732, createdName=ms1000002125960899, createdTime=Fri Jan 12 01:07:59 CST 2024, time=2024-01-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=591339, encodeId=6cce5913394f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投了一篇综述，送审很快，1个月后收到三个审稿人意见，比较中肯，对修稿帮助很大，认真修改了文章，再次送审，3周后返回直接录用。效率很高，期间和编辑通过几次邮件，基本都是秒回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd6e2356258, createdName=122c0493m86(暂无昵称), createdTime=Wed May 20 20:26:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574838, encodeId=704f5e483848, content=投稿1天变成decision in process，2天后变成revise，现在一直是，请问各位，这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aee52167475, createdName=1204566cm41(暂无昵称), createdTime=Thu Aug 15 00:00:00 CST 2019, time=2019-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113030, encodeId=feec21130303d, content=请问做分子机制需要提交所有的原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2e06431458, createdName=ms3000002026677147, createdTime=Sat Feb 04 18:33:13 CST 2023, time=2023-02-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111102, encodeId=1d45211110209, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：神经介入方向； 我是邀稿的，速度很快，1个月不到，要求比较低； 适合发点小东西，版面费2k刀（注意这个）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/16/e92e0d4a11f64c95514f68e46da6590a.jpg, createdBy=51fb2303021, createdName=errormore, createdTime=Sat Jan 21 19:38:41 CST 2023, time=2023-01-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=578255, encodeId=9c375e82550a, content=现在是oa收费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aee52167475, createdName=1204566cm41(暂无昵称), createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231110, encodeId=2b4b1231110ce, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：peer review 快一个月了，一直没有消息，什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2f25326618, createdName=148bdbbbm57暂无昵称, createdTime=Thu Jul 07 10:21:16 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854981, encodeId=587585498166, content=昨天刚投了一篇结题文章，MedSci上面的关于这本期刊的网址信息不对，我自己通过web of science找到了准确的官方信息： 期刊官方网站：https://jin.imrpress.com/ 期刊投稿网址：https://www.editorialmanager.com/joins/default.aspx , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Fri Nov 15 11:13:58 CST 2019, time=2019-11-15, status=1, ipAttribution=)]

2019-10-21 1204566cm41(暂无昵称)

现在是oa收费

145 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200128, encodeId=2d4222001287f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一个多月了，还在peer review，请问这个杂志的审稿速度咋样，很慌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5be79155125, createdName=ms9000001054284223, createdTime=Wed Apr 24 14:08:55 CST 2024, time=2024-04-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198714, encodeId=a75a2198e14bd, content=请问一下这个杂志接收临床研究的文章吗？是否需要提供患者的原始数据？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65861397214, createdName=chenyongdaniel, createdTime=Tue Apr 16 01:29:50 CST 2024, time=2024-04-16, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2180882, encodeId=f19b2180882da, content=..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed6c8739732, createdName=ms1000002125960899, createdTime=Fri Jan 12 01:07:59 CST 2024, time=2024-01-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=591339, encodeId=6cce5913394f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投了一篇综述，送审很快，1个月后收到三个审稿人意见，比较中肯，对修稿帮助很大，认真修改了文章，再次送审，3周后返回直接录用。效率很高，期间和编辑通过几次邮件，基本都是秒回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd6e2356258, createdName=122c0493m86(暂无昵称), createdTime=Wed May 20 20:26:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574838, encodeId=704f5e483848, content=投稿1天变成decision in process，2天后变成revise，现在一直是，请问各位，这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aee52167475, createdName=1204566cm41(暂无昵称), createdTime=Thu Aug 15 00:00:00 CST 2019, time=2019-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113030, encodeId=feec21130303d, content=请问做分子机制需要提交所有的原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2e06431458, createdName=ms3000002026677147, createdTime=Sat Feb 04 18:33:13 CST 2023, time=2023-02-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111102, encodeId=1d45211110209, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：神经介入方向； 我是邀稿的，速度很快，1个月不到，要求比较低； 适合发点小东西，版面费2k刀（注意这个）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/16/e92e0d4a11f64c95514f68e46da6590a.jpg, createdBy=51fb2303021, createdName=errormore, createdTime=Sat Jan 21 19:38:41 CST 2023, time=2023-01-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=578255, encodeId=9c375e82550a, content=现在是oa收费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aee52167475, createdName=1204566cm41(暂无昵称), createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231110, encodeId=2b4b1231110ce, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：peer review 快一个月了，一直没有消息，什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2f25326618, createdName=148bdbbbm57暂无昵称, createdTime=Thu Jul 07 10:21:16 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854981, encodeId=587585498166, content=昨天刚投了一篇结题文章，MedSci上面的关于这本期刊的网址信息不对，我自己通过web of science找到了准确的官方信息： 期刊官方网站：https://jin.imrpress.com/ 期刊投稿网址：https://www.editorialmanager.com/joins/default.aspx , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Fri Nov 15 11:13:58 CST 2019, time=2019-11-15, status=1, ipAttribution=)]

2022-07-07 148bdbbbm57暂无昵称

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：神经病学
经验分享：peer review 快一个月了，一直没有消息，什么情况

53 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200128, encodeId=2d4222001287f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：投了一个多月了，还在peer review，请问这个杂志的审稿速度咋样，很慌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5be79155125, createdName=ms9000001054284223, createdTime=Wed Apr 24 14:08:55 CST 2024, time=2024-04-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198714, encodeId=a75a2198e14bd, content=请问一下这个杂志接收临床研究的文章吗？是否需要提供患者的原始数据？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65861397214, createdName=chenyongdaniel, createdTime=Tue Apr 16 01:29:50 CST 2024, time=2024-04-16, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2180882, encodeId=f19b2180882da, content=..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed6c8739732, createdName=ms1000002125960899, createdTime=Fri Jan 12 01:07:59 CST 2024, time=2024-01-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=591339, encodeId=6cce5913394f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投了一篇综述，送审很快，1个月后收到三个审稿人意见，比较中肯，对修稿帮助很大，认真修改了文章，再次送审，3周后返回直接录用。效率很高，期间和编辑通过几次邮件，基本都是秒回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd6e2356258, createdName=122c0493m86(暂无昵称), createdTime=Wed May 20 20:26:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574838, encodeId=704f5e483848, content=投稿1天变成decision in process，2天后变成revise，现在一直是，请问各位，这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aee52167475, createdName=1204566cm41(暂无昵称), createdTime=Thu Aug 15 00:00:00 CST 2019, time=2019-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113030, encodeId=feec21130303d, content=请问做分子机制需要提交所有的原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2e06431458, createdName=ms3000002026677147, createdTime=Sat Feb 04 18:33:13 CST 2023, time=2023-02-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111102, encodeId=1d45211110209, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：神经介入方向； 我是邀稿的，速度很快，1个月不到，要求比较低； 适合发点小东西，版面费2k刀（注意这个）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/16/e92e0d4a11f64c95514f68e46da6590a.jpg, createdBy=51fb2303021, createdName=errormore, createdTime=Sat Jan 21 19:38:41 CST 2023, time=2023-01-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=578255, encodeId=9c375e82550a, content=现在是oa收费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aee52167475, createdName=1204566cm41(暂无昵称), createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231110, encodeId=2b4b1231110ce, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：peer review 快一个月了，一直没有消息，什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2f25326618, createdName=148bdbbbm57暂无昵称, createdTime=Thu Jul 07 10:21:16 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854981, encodeId=587585498166, content=昨天刚投了一篇结题文章，MedSci上面的关于这本期刊的网址信息不对，我自己通过web of science找到了准确的官方信息： 期刊官方网站：https://jin.imrpress.com/ 期刊投稿网址：https://www.editorialmanager.com/joins/default.aspx , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Fri Nov 15 11:13:58 CST 2019, time=2019-11-15, status=1, ipAttribution=)]

2019-11-15 ms3860263520721591

昨天刚投了一篇结题文章，MedSci上面的关于这本期刊的网址信息不对，我自己通过web of science找到了准确的官方信息：
期刊官方网站：https://jin.imrpress.com/
期刊投稿网址：https://www.editorialmanager.com/joins/default.aspx

0 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务